Kawasaki, Japan

Yumi Ando

This inventor holds 1 USPTO granted patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yumi Ando. Retrieved from https://idiyas.com/inventor/yumi-ando-5oouj0ot

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yumi Ando: Innovator in Stem Cell Culture

Introduction

Yumi Ando is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of stem cell research, particularly through his innovative patent.

Latest Patents

Yumi Ando holds a patent for a medium for culturing stem cells. This culture media contains albumin that carries a reduced amount of fatty acid, making it particularly useful for culturing stem cells. His work in this area has the potential to advance stem cell therapies and research.

Career Highlights

Yumi Ando is associated with Ajinomoto Co., Ltd., a company known for its commitment to research and development in biotechnology and food products. His role at the company has allowed him to focus on innovative solutions in the field of life sciences.

Collaborations

Yumi Ando has collaborated with talented coworkers, including Yoko Kuriyama and Sho Senda. These collaborations have fostered a creative environment that encourages the development of groundbreaking ideas.

Conclusion

Yumi Ando's contributions to stem cell culture represent a significant advancement in biotechnology. His innovative approach and collaboration with skilled professionals continue to drive progress in this vital field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…